Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S....
Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%, as analysts weighed in on...
Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results from a Phase 2 trial of...
Abbott Laboratories ABT said that a Food and Drug Administration panel voted in favor of the safety profile of its...
AbbVie Inc.’s stock fell 0.5% early Monday, after the biotech lowered its first-quarter guidance to reflect the dilutive impact of...
For all the attention paid to the highflying tech giants dubbed the Magnificent Seven, there’s another grouping that has kept...
An investor who needs income right now has an advantage — short-term interest rates remain high and you can easily...
A record number of people in the U.S. will turn 65 this year. Here’s how the phenomenon known as Peak...
Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues dropped for one of its...